Neuromyelitis Optica in a Patient from Family with both Myotonic Dystrophy Type 1 and 2

Area of Science:

• Genetics
• Neurology
• Clinical Medicine

Background:

• Myotonic dystrophy type 1 (DM1) and type 2 (DM2) are distinct genetic neuromuscular disorders.
• Co-occurrence of DM1 and DM2 in a single family is rare.
• Neuromyelitis optica (NMO) is a rare autoimmune disorder affecting the central nervous system.

Purpose of the Study:

• To report a family with co-segregating DM1 and DM2 mutations.
• To describe a family member with DM1, DM2, and NMO.
• To emphasize the importance of comprehensive genetic screening for myotonic dystrophies.

Main Methods:

• Case report of a family with genetic testing.
• Clinical examination of affected individuals.
• Review of medical history and genetic findings.

Main Results:

• The index case presented with DM2 mutation and DM1 protomutation, developing symptoms later in life.
• Family members showed varying combinations of DM1 and DM2 mutations with associated clinical manifestations.
• One individual with both DM1 and DM2 mutations also developed NMO.

Conclusions:

• Genetic screening for both DM1 and DM2 is crucial in families with suspected myotonic dystrophy.
• A positive result for one type of myotonic dystrophy should not preclude testing for the other.
• Comprehensive genetic evaluation is essential for accurate diagnosis and management of complex neurological cases.